Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores beta1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors[1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 188.00 | |
5 mg | In stock | $ 342.00 | |
10 mg | In stock | $ 558.00 | |
25 mg | In stock | $ 898.00 | |
50 mg | In stock | $ 1,230.00 | |
100 mg | In stock | $ 1,660.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 353.00 |
Description | Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores beta1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors[1]. |
Molecular Weight | 273.28 |
Formula | C15H15NO4 |
CAS No. | 140674-76-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/ml (219.56 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AG957 140674-76-6 Angiogenesis Cytoskeletal Signaling Tyrosine Kinase/Adaptors Bcr-Abl paxillin NSC654705 c-Abl lipopolysaccharide AG 957 Tyrphostin AG-957 integrins leukemia tyrosine Tyrphostin AG 957 hematopoiesis NSC-654705 NSC 654705 AG-957 Tyrphostin AG957 kinase BCR/ABL inhibit cytoskeleton Inhibitor Chronic myelogenous inhibitor